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OBJECTIVE — The purpose of this study was to determine the frequency of recurrent ges-
tational diabetes mellitus (GDM) and to ﬁnd risk factors that can predict the recurrence of GDM
in Korean women with previous GDM.
RESEARCH DESIGN AND METHODS — We evaluated women who had GDM in an
index pregnancy (1993–2001) and a subsequent pregnancy by 2003. An oral glucose tolerance
test (OGTT) was performed during the index pregnancy and 2 months postpartum. The recur-
rence rate of GDM was assessed among 111 women who had a subsequent pregnancy. Multi-
variate logistic regression analysis was used to identify independent predictors of recurrent
GDM.
RESULTS — ThefrequencyofrecurrentGDMinsubsequentpregnancieswas45.0%(95%CI
35.6–54.4%). Women with impaired fasting glucose and/or impaired glucose tolerance 2
months postpartum were at increased risk for recurrent GDM (relative risk 2.31, 95% CI
1.24–4.30). Higher BMI before the subsequent pregnancy (P  0.024), higher fasting glucose
concentration (P  0.007) 2 months postpartum, and lower 1-h insulin concentration (P 
0.004) of the diagnostic OGTT in the index pregnancy were independent risk factors for recur-
rence of GDM in subsequent pregnancies.
CONCLUSIONS — GDM recurred in nearly half of subsequent pregnancies in Korean
women. Fasting glucose 2 months postpartum might be a clinically valuable predictor of recur-
rent GDM risk.
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G
estational diabetes mellitus (GDM)
is deﬁned as glucose intolerance of
variable severity with onset or ﬁrst
recognition during pregnancy (1). GDM
is associated with adverse outcomes of
pregnancysuchaspreeclampsia,cesarean
delivery, macrosomia, and birth trauma
(1,2). Furthermore, women with GDM
andtheiroffspringareatincreasedriskfor
the development of diabetes later in life
(3–5). Recently, a randomized clinical
trial demonstrated that treatment of ma-
ternal hyperglycemia signiﬁcantly re-
duced perinatal morbidity in GDM (6). If
wecouldidentifyriskfactorsforrecurrent
GDM, we might possibly prevent its recur-
rence. It may also be possible to reduce
perinatal morbidity by early diagnosis
and optimal treatment of recurrent GDM
during the subsequent pregnancy.
The reported frequency of recurrent
GDM varies widely, from 30 to 84%, de-
pending on the ethnicity of the subjects
and the diagnostic criteria used (7). Al-
thoughonestudyreportedtherecurrence
rateofGDMinAsianwomen(8),thesam-
ple size was small and widely used diag-
nostic criteria for GDM were not applied.
Risk factors associated with recur-
rence of GDM have also varied among re-
ported studies (7,9). In general, greater
maternalage,obesity,degreeofhypergly-
cemia in the index pregnancy, increased
weight gain, and short interval between
pregnancies were suggested to be associ-
ated with recurrent GDM (7–11). How-
ever, biochemical parameters, such as
glucose and insulin levels during preg-
nancy and/or early postpartum, have not
often been evaluated as risk factors for re-
currenceofGDM.Itisrecommendedthat
women with GDM have a glucose toler-
ance test to reevaluate glycemic status at
the ﬁrst postpartum visit (12). We hy-
pothesized that the early postpartum glu-
cose concentration might provide
important information for predicting risk
of recurrence of GDM. In this study we
evaluated the recurrence rate of GDM in
Korean women and risk factors for its re-
currence, including a postpartum oral
glucose tolerance test (OGTT).
RESEARCH DESIGN AND
METHODS— We conducted a retro-
spective study among subjects with the
ﬁrst diagnosis of GDM at Cheil General
Hospital, Seoul, Korea, between July
1993 and March 2001. A total of 792
women with the ﬁrst diagnosis of GDM
were identiﬁed during the study period.
Among them, 120 women had a subse-
quent pregnancy by March 2003. The av-
erage duration of surveillance for
subsequent pregnancy was 5.3  2.3
years.
Our protocol for screening and diag-
nosis of GDM has been described in pre-
vious publications (13,14). Brieﬂy, all
pregnant women who had not been iden-
tiﬁedashavingglucoseintolerancebefore
24 weeks were screened for GDM be-
tween 24 and 28 weeks’ gestation using
the 50-g 1-h glucose challenge test. A
plasma glucose concentration of 130
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and was followed by a diagnostic OGTT.
The diagnosis of GDM was made accord-
ing to the criteria of the Third Interna-
tional Workshop-Conference on
Gestational Diabetes Mellitus (1). The
threshold values were fasting 105 mg/dl,
1h190 mg/dl, 2 h 165 mg/dl, and 3 h
145 mg/dl.
After delivery, women with GDM
were scheduled for a 75-g OGTT 2
months postpartum. They were asked to
consume at least 150 g carbohydrate/day
for 3 days and fast for 10 h before the
OGTT. Postpartum OGTT results were
interpreted to American Diabetes Associ-
ation criteria (15). Women with diabetes
at the postpartum evaluation were ex-
cluded from this analysis. At the time of
postpartum testing, women with GDM
were counseled regarding risks of recur-
rence of GDM and type 2 diabetes in the
future.
At the screening test for both the in-
dex and subsequent pregnancies, the fol-
lowing information was recorded
prospectively for each patient: age,
height, prepregnancy weight from pa-
tient’s recall, present weight, obstetric
history including gestational age and par-
ity, and family history of diabetes in the
ﬁrst-degree relatives. Maternal weight
and pregnancy outcome were also re-
corded at the time of delivery. The inter-
val of time between two pregnancies was
also calculated.
Plasma glucose concentration was
measured with a glucose oxidase method
using a YSI 2300 STAT (YSI, Yellow
Springs, Ohio). The concentration of in-
sulin was measured using a human-
speciﬁc radioimmunoassay kit (Linco
Research, St. Charles, MO). The intra-
assay and interassay coefﬁcients of varia-
tion for insulin measurements were 4.5
and 8.8%, respectively. Insulin resistance
was estimated by homeostasis model as-
sessment (HOMA-IR) according to the
methoddescribedbyMatthewsetal.(16).
Differences between the recurrent
GDM group and non-GDM group were
analyzed by Student’s t test and 
2 test.
The insulin concentration was log-
transformedtocorrectfornonnormaldis-
tributions. Kruskal-Wallis and Fisher’s
exact tests were also used to analyze non-
normally distributed and dichotomous
variables (e.g., family history of diabetes
andparity).Potentialriskfactors,selected
by clinical and/or statistical signiﬁcance,
were examined using multivariate logistic
regression analysis to identify indepen-
dent risk factors for recurrence of GDM.
The receiver operating characteristics
(ROC)curvewasplottedtodeterminethe
cutoffvalueofpostpartumfastingglucose
level that could best predict the recur-
rence of GDM. Data are presented as
means  SD and percentage for normally
distributed data and otherwise as median
(range). P  0.05 was considered to be
signiﬁcant. Statistical analyses were per-
formed using SPSS 12.0 for Windows
software (SPSS, Chicago, IL).
RESULTS
Recurrent GDM
Between July 1993 and March 2001, we
identiﬁed 792 women with the ﬁrst diag-
nosis of GDM. Of them, 102 (12.9%) had
tubal ligation immediately after delivery.
Of the remaining 690 subjects who were
followed up until March 2003, 120
(17.4%) were found to have a subsequent
pregnancy.
Five women with diabetes at the 2
months postpartum test were excluded
from the analysis. An additional four
women did not have an OGTT during the
subsequent pregnancy and were also ex-
cluded from the analysis. Results from
111 women were analyzed, and 50
(45.0%, 95% CI 35.6–54.4%) women
had recurrent GDM at a subsequent preg-
nancy. Of these 111 women, 86 had re-
ceived a 75-g OGTT 2 months after the
index pregnancy. Among the 86 subjects,
31 (36.0%) had abnormal glucose toler-
ance (one had isolated impaired fasting
glucose [IFG], 24 had isolated impaired
glucose tolerance [IGT], and 6 had IFG
andIGT),and55womenhadnormalglu-
cose tolerance (NGT). In the abnormal
glucose tolerance group, 21 (67.7%)
women had recurrence of GDM, whereas
only 20 (36.4%) of the NGT group had
recurrent GDM. The relative risk (RR) of
recurrent GDM in the subgroup with ab-
normalpostpartumglucosetolerancewas
2.31(95%CI1.24–4.30)comparedwith
that for the NGT group.
Demographic factors related to
recurrence of GDM
Demographic characteristics of women
who had recurrent GDM and those with-
out GDM during a subsequent pregnancy
are shown in Table 1. Those with recur-
rent GDM had higher prepregnancy BMI
and body weight, both at index and at the
subsequent pregnancy, and weighed
more at the time of delivery than the non-
GDM group. Birth weight of infants was
also greater in the recurrent GDM group.
Theproportionofsubjectsreceivinginsu-
Table 1—Demographic characteristics of women with NGT and recurrent GDM during a
subsequent pregnancy
NGT
Recurrent
GDM P value
Index pregnancy
Age (years) 28.9  3.4 29.7  3.2 0.20
Prepregnancy weight (kg) 52.9  7.5 57.5  11.5 0.02
Prepregnancy BMI (kg/m
2) 21.1  2.7 23.0  3.9 0.01
Weight at delivery (kg) 64.7  8.2 69.9  11.3 0.01
Family history of diabetes (%) 32.8 44.0 0.24
Baby weight (g) 3192  449 3387  494 0.04
Body weight change during
pregnancy (kg)
12.0  4.0 12.3  5.5 0.81
Gestational age at diagnosis of
GDM (weeks)
29.1  2.9 28.2  3.4 0.11
Insulin treatment (%) 4.9 32.0 0.01
Subsequent pregnancy
Age (years) 31.3  3.4 32.4  3.3 0.09
Body weight change between
pregnancies (kg)
1.7  3.9 1.2  3.7 0.52
Prepregnancy weight (kg) 54.1  7.6 59.1  10.6 0.01
Prepregnancy BMI (kg/m
2) 21.5  2.7 23.8  3.7 0.01
Parity 1.1  0.3 1.1  0.4 0.58
Interval from index to subsequent
pregnancy (months)
29.8  13.8 32.8  18.3 0.34
Data are means  SD unless otherwise indicated.
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the recurrent GDM group. The average
interval between the two pregnancies was
not different.
OGTT and recurrence of GDM. The re-
current GDM group had signiﬁcantly
higherfastingand1-hand2-hOGTTglu-
cose concentrations during the index
pregnancy compared with the non-GDM
group (Table 2). Fasting insulin concen-
tration and HOMA-IR were also signiﬁ-
cantly higher in the recurrent GDM
group. However, the recurrent GDM
group had signiﬁcantly lower 1- and 3-h
OGTT insulin concentration.
In the 2 months postpartum 75-g
OGTT,therecurrentGDMgrouphadsig-
niﬁcantly higher fasting and 1-h glucose
concentrationsthanthenon-GDMgroup.
Fasting, 1-h, and 2-h insulin concentra-
tions did not differ in the two groups.
HOMA-IR was again increased in the re-
current GDM group.
Independent risk factors of recurrent
GDM. Multiple logistic regression analy-
sis was performed to test for independent
risk factors for GDM recurrence. We in-
cluded variables that were clinically im-
portant and signiﬁcantly different
betweenthetwogroupsinasinglelogistic
model (Table 3). The prepregnancy BMI
of subsequent pregnancy, the 1-h insulin
level of OGTT in the index pregnancy,
and the fasting glucose concentration of
the 2 months postpartum OGTT were in-
dependent predictors of recurrent GDM.
To further examine the association
between these risk factors and recurrence
of GDM, we stratiﬁed the study subjects
into quartiles based on the 1-h insulin
concentration of the OGTT in the index
pregnancy and the fasting plasma glucose
concentration of the postpartum OGTT.
As shown in Table 4, the recurrence of
GDM was higher as fasting glucose con-
centration increased and 1-h insulin con-
centration decreased. Those with a 1-h
insulin concentration 220 pmol/l had a
1.9-fold greater risk of recurrent GDM
than those with insulin concentration
540 pmol/l. Women with a fasting
plasma glucose concentration 100
mg/dl at the 2 months postpartum OGTT
hada4.8-foldhigherriskofhavingrecur-
rentGDMcomparedwiththosewithfast-
ing plasma glucose 85 mg/dl. The ROC
curve was drawn between fasting plasma
glucose concentration and the recurrence
of GDM. The cutoff value of 93 mg/dl en-
suredthebestsensitivityandspeciﬁcityof
65.1 and 70.5%, respectively (area under
the ROC curve 0.73, 95% CI 0.62–0.83).
CONCLUSIONS — This hospital-
basedcohortstudydemonstratedthatthe
frequency of recurrent GDM in subse-
quent pregnancies was 45.0% in Korean
women. Independent risk factors for re-
current GDM were higher BMI before the
subsequent pregnancy, the 1-h insulin
concentration of the OGTT in the index
pregnancy, and the fasting glucose con-
centration 2 months postpartum. One of
the key features of this study was that we
examined whether recurrence of GDM
was associated with indexes of insulin re-
sistance and -cell function (OGTT insu-
lin concentration) along with index
pregnancy and postpartum OGTT glu-
cose concentrations. Many risk factors of
previous reports, such as early diagnosis
of GDM, the need for insulin treatment,
and macrosomia, are probably surrogates
of -cell dysfunction and/or severity of
glucoseintolerance.Anotheradvantageof
our study is that the subjects have been
followed up for a long period with the
average interval of time between index
andsubsequentpregnanciesbeing30.5
months. The longer the period of surveil-
lance, the larger the number of women
with a subsequent pregnancy. This might
be one of the reasons why it is difﬁcult to
compare reports of rates of GDM recur-
rence. The risk factors for recurrence
might also be different with a relatively
short versus a relatively long interpreg-
nancy interval.
Weattemptedtoprovidecomprehen-
sive information about the reproductive
history of our GDM cohort. From the 792
index GDM women, we documented that
102 (12.9%) had undergone tubal liga-
tion. The parity of the 690 women after
index GDM was 1.24. The total fertility
rate of Korean women during the study
period(1993–2003)was1.47(17).Based
on national demographics, we estimated
that there might be 159 (690  0.23) ad-
ditionalpregnanciesduringthefollow-up
period of 5 years. The number that we
identiﬁed was somewhat less than that.
Wedonotknowiftherewerepregnancies
at other hospitals that we did not capture.
Several researchers have applied the
same diagnostic criteria used in this
study.ThefrequencyofrecurrentGDMin
our study (45.0%) was similar to that
(35.6%) in the report of MacNeill et al.
(9), which was obtained from 651 Cana-
Table 2—Comparison of metabolic variables between normal pregnancy and recurrent GDM
group
Normal Recurrent GDM P value
Index pregnancy (100-g OGTT)
Glucose (mg/dl)
Fasting 84.4  17.4 94.6  24.5 0.02
1 h 190.8  20.0 202.7  35.0 0.03
2 h 174.5  17.1 188.9  38.5 0.02
3 h 147.0  19.1 149.4  49.6 0.70
Insulin (pmol/l)*
Fasting 60 (13–180) 76 (19–222) 0.01
1 h 390 (66–1,340) 288 (56–1,399) 0.01
2 h 480 (49–1,616) 455 (96–1,669) 0.42
3 h 408 (75–1,680) 317 (126–1,548) 0.04
HOMA-IR* 2.20 (0.43–6.16) 3.18 (0.58–20.65) 0.01
2 months postpartum after index pregnancy
(75-g OGTT)
Glucose (mg/dl)
Fasting 88.8  7.9 97.9  11.9 0.01
1 h 155.2  35.6 182.1  37.5 0.01
2 h 122.2  24.5 134.9  28.5 0.05
Insulin (pmol/l)*
Fasting 41 (10–126) 48 (13–132) 0.09
1 h 234 (54–1,266) 264 (102–846) 0.71
2 h 189 (31–870) 186 (102–600) 0.47
HOMA-IR* 1.38 (0.36–5.19) 2.04 (0.55–5.25) 0.01
Abnormal glucose tolerance (%) 22.7  6.4 54.1  8.3 0.01
Glucose data are means  SD, and insulin and HOMA-IR data are given as median (range). *Frequency of
abnormal glucose tolerance values are means  SEM. These variables were log-transformed before analyses.
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inantly white, and the underlying
incidence of GDM was estimated to be
2%, which was similar to that in a Ko-
rean population (14). In contrast, in the
reports of Spong et al. (10) and Major et
al. (9), whose populations were com-
posedmainlyofHispanics,therecurrence
rates of GDM were about 68% in both
studies. One of the possible explanations
for differences in GDM recurrence rate is
that the underlying incidence of GDM in
Hispanics was as high as 5% (18). Higher
incidence of GDM might reﬂect increased
susceptibility of having GDM and its re-
currence in a certain population. We
speculated that these differences in eth-
nicity and underlying incidence of GDM
could inﬂuence the recurrence rate of
GDM in a given population.
Fasting,1-h,and2-hglucoseconcen-
trations of the OGTT in the index preg-
nancy were signiﬁcantly higher in the
recurrent GDM group. This ﬁnding was
in agreement with results of previous
studies showing that higher glucose con-
centrations for an OGTT were associated
with increased risk of recurrent GDM.
Gaudier et al. (19) reported that women
with recurrent GDM had higher 1- and
2-h glucose concentrations. Spong et al.
(10) also reported that fasting and 2-h
OGTT glucose concentrations were
higher in the recurrent GDM group.
Therefore, it would be acceptable to state
that the severity of hyperglycemia during
the index pregnancy is related to recur-
rent GDM risk.
It is interesting that the 1-h insulin
concentration was signiﬁcantly lower in
the recurrent GDM group than that in the
non-GDMgroup.Althoughthefastingin-
sulin concentration was higher in the re-
current GDM group, the increment of
insulin concentration at 1 h was signiﬁ-
cantly lower (275  250 vs. 400  270
pmol/l).Furthermore,alower1-hinsulin
level was an independent risk factor for
recurrence of GDM. This ﬁnding implies
that the insulin secretion reservoir might
be decreased in the recurrent GDM
group. There were similar reports stating
that -cell function is decreased in pa-
tients with GDM (20,21), but we did not
evaluate the disposition index, which
measurespancreaticcompensationforin-
sulin resistance. However, our result sug-
gests that patients with poor -cell
compensation for insulin resistance at
pregnancy are more prone to have recur-
renceofGDMinasubsequentpregnancy.
It is worth noting that factors identi-
ﬁed as independent predictors of recur-
rentGDMarethesameasthosethatpredict
the progression to diabetes after GDM.
Several studies have shown that impaired
-cell function during the index preg-
nancyandearlypostpartumOGTTvalues
were factors that predicted future devel-
opment of type 2 diabetes in women with
GDM(22,23).Theseﬁndingssuggestthat
a common pathophysiological basis un-
derliesthetwodiseases.Furthermore,im-
paired-cellfunctionandearlymetabolic
derangement seem to have a crucial effect
on future glucose metabolism.
It is recommended that maternal gly-
cemic status be evaluated at least 2
months after delivery (15). Among 111
patients with index pregnancy GDM, 86
(77.4%) patients had a 75-g OGTT at 2
months postpartum. Although 22.6% of
the women did not have a postpartum
OGTT, excluding those patients did not
result in differences in clinical character-
istics and frequency of recurrent GDM
(data not shown). Analysis of the 75-g
OGTT at 2 months postpartum after the
index pregnancy showed that 34.1% of
patients had abnormal glucose tolerance.
Women showing abnormal glucose toler-
ance had as much as 2.3 times increased
risk of having recurrent GDM. Further-
more, elevated fasting glucose concentra-
tion at 2 months postpartum was an
independent risk factor for recurrence of
GDM. When we set the cutoff value of
fastingglucoseconcentrationat93mg/dl,
it had acceptable sensitivity and speciﬁc-
ity to predict recurrence of GDM. Exam-
ination of results of the 75-g OGTT,
especially the fasting glucose level at 2
Table 3—Independent risk factors for recurrence of GDM according to multivariate logistic
regression analysis
Unstandardized
coefﬁcients
P value  SEM
Age at subsequent pregnancy 0.098 0.106 0.355
Prepregnancy BMI of subsequent pregnancy 0.277 0.123 0.024
Parity 	0.364 1.185 0.759
Insulin treatment during index pregnancy 1.248 1.176 0.288
Interval between the two pregnancies 	0.001 0.021 0.952
1 h log insulin of OGTT at index pregnancy* 	4.096 1.410 0.004
Fasting plasma glucose at 2 months postpartum 0.098 0.037 0.007
Variablesincluded:ageatsubsequentpregnancy,prepregnancyBMIofsubsequentpregnancy,parity,usage
of insulin during index pregnancy, interval between the two pregnancies, fasting and 2-h glucose levels and
fasting and 1-h insulin levels of the diagnostic OGTT of index pregnancy, and fasting and 2-h glucose levels
at 2 months postpartum. *This variable was log-transformed before analysis.
Table 4—RR for recurrent GDM according to quartiles of independent predictors
Variable
Recurrence of
GDM (%) RR (95% CI)
1 h insulin of OGTT at index
pregnancy (pmol/l)
220 18 (72.0) 1.90 (1.12–3.21)
220–339 12 (42.9) 1.13 (0.60–2.13)
340–519 9 (31.0) 0.82 (0.40–1.67)
520 11 (37.9) 1
Fasting plasma glucose at 2 months
postpartum (mg/dl)*
85 6 (27.3) 1
85–93 9 (37.5) 1.24 (0.72–2.15)
94–99 11 (50.0) 1.58 (0.89–2.82)
100 19 (86.4) 4.81 (1.67–13.92)
Data are n (%) or RR (95% CI). RR was calculated using 86 recurrent cases of GDM according to quartiles of
1-h insulin level of diagnostic OGTT at the index pregnancy and fasting glucose level at 2 months postpar-
tum. *The number of subjects analyzed for fasting glucose was 90, as there were four additional subjects
whose fasting glucose level was measured.
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fying women who are at high risk for
GDM recurrence. These subjects should
be more intensively monitored for the re-
currence, and efforts should be made to
improve the metabolic risk factors before
they have a subsequent pregnancy.
In summary, GDM recurs in nearly
halfofsubsequentpregnanciesamongthe
Koreanpopulation.Adecreased1-hinsu-
lin concentration for the OGTT in the in-
dex pregnancy, higher BMI before
subsequentpregnancy,andfastinghyper-
glycemia at 2 months postpartum were
independent risk factors for the recur-
rence of GDM. Early postpartum exami-
nation of maternal glycemic status could
help to assess the risk of GDM at subse-
quent pregnancy.
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